Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Martin Cannon

Concepts (295)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Dendritic Cells
26
2023
132
3.870
 Why?
Ovarian Neoplasms
23
2023
448
3.840
 Why?
Cancer Vaccines
13
2020
78
3.100
 Why?
Immunotherapy
12
2019
238
1.980
 Why?
Th17 Cells
3
2020
26
1.560
 Why?
Antigens, Neoplasm
11
2019
151
1.380
 Why?
CD4-Positive T-Lymphocytes
8
2023
163
1.100
 Why?
Uterine Cervical Neoplasms
13
2011
274
0.990
 Why?
Oncogene Proteins, Viral
7
2011
52
0.840
 Why?
Neoplasm Recurrence, Local
3
2020
618
0.790
 Why?
T-Lymphocytes, Regulatory
6
2011
85
0.760
 Why?
T-Lymphocytes, Cytotoxic
12
2013
65
0.730
 Why?
Indoleamine-Pyrrole 2,3,-Dioxygenase
3
2014
16
0.680
 Why?
Lymphocytes, Tumor-Infiltrating
4
2019
76
0.630
 Why?
CD8-Positive T-Lymphocytes
11
2023
115
0.590
 Why?
Neoplasms
4
2019
1233
0.590
 Why?
Antibodies, Monoclonal
5
2019
458
0.570
 Why?
Interleukin-17
2
2020
36
0.560
 Why?
DNA-Binding Proteins
5
2007
436
0.560
 Why?
p38 Mitogen-Activated Protein Kinases
2
2014
96
0.540
 Why?
Ascites
1
2014
28
0.470
 Why?
T-Lymphocytes
5
2017
338
0.460
 Why?
Immunologic Surveillance
2
2011
10
0.460
 Why?
Female
42
2023
26329
0.420
 Why?
Cytokines
4
2014
612
0.420
 Why?
Signal Transduction
3
2017
1617
0.420
 Why?
Carcinoma
2
2017
137
0.410
 Why?
Immunotherapy, Active
1
2011
4
0.390
 Why?
T-Lymphocytes, Helper-Inducer
2
2011
42
0.390
 Why?
Serine Endopeptidases
3
2009
52
0.390
 Why?
Cytotoxicity, Immunologic
7
2011
54
0.380
 Why?
Humans
52
2023
49827
0.370
 Why?
Adoptive Transfer
1
2009
39
0.340
 Why?
Immunotherapy, Adoptive
3
2005
154
0.330
 Why?
Interferon-gamma
7
2020
174
0.320
 Why?
Epitopes, T-Lymphocyte
3
2008
24
0.310
 Why?
Lymphocyte Activation
3
2005
172
0.290
 Why?
Adjuvants, Immunologic
3
2011
51
0.280
 Why?
Herpesvirus 4, Human
2
2005
35
0.280
 Why?
Papillomavirus Vaccines
1
2007
61
0.280
 Why?
Immunodominant Epitopes
2
2008
8
0.280
 Why?
Animals
15
2023
13150
0.240
 Why?
Dependovirus
3
2011
101
0.240
 Why?
Cell Line, Tumor
12
2017
1402
0.230
 Why?
HLA-A2 Antigen
3
2009
11
0.230
 Why?
Cell Transformation, Viral
1
2003
25
0.220
 Why?
Cell Line, Transformed
1
2003
72
0.220
 Why?
Poxviridae Infections
1
2022
4
0.220
 Why?
Poxviridae
1
2022
7
0.210
 Why?
Myxoma virus
1
2022
14
0.210
 Why?
Interferon Type I
1
2022
25
0.210
 Why?
Cystadenocarcinoma, Serous
5
2009
70
0.210
 Why?
Vaccination
4
2010
268
0.210
 Why?
Papillomavirus E7 Proteins
5
2011
31
0.200
 Why?
Receptor, erbB-2
4
2008
73
0.200
 Why?
Disease-Free Survival
2
2020
457
0.200
 Why?
Interleukin-10
2
2017
84
0.200
 Why?
Genes, MHC Class I
3
2008
11
0.200
 Why?
Testis
2
2011
69
0.190
 Why?
Injections, Intradermal
1
2020
14
0.190
 Why?
Membrane Proteins
4
2011
342
0.190
 Why?
Macrophages
4
2022
364
0.190
 Why?
Immunity, Humoral
1
2020
22
0.190
 Why?
Coculture Techniques
3
2014
146
0.180
 Why?
Folate Receptor 1
1
2020
24
0.180
 Why?
Flow Cytometry
8
2013
470
0.180
 Why?
Cell Movement
2
2019
247
0.180
 Why?
Enzyme-Linked Immunosorbent Assay
2
2013
245
0.180
 Why?
Carcinoma, Lewis Lung
1
2019
10
0.170
 Why?
B-Lymphocytes
5
2017
170
0.170
 Why?
Repressor Proteins
3
2011
151
0.170
 Why?
Self Tolerance
1
2019
1
0.170
 Why?
Costimulatory and Inhibitory T-Cell Receptors
1
2019
1
0.170
 Why?
Melanoma, Experimental
1
2019
45
0.170
 Why?
Transplantation, Autologous
1
2020
456
0.160
 Why?
Aged
12
2020
9272
0.160
 Why?
Cells, Cultured
6
2014
1571
0.150
 Why?
Cytotoxicity Tests, Immunologic
4
2005
28
0.150
 Why?
N-Acetylglucosaminyltransferases
1
2017
14
0.150
 Why?
Middle Aged
16
2020
11997
0.150
 Why?
Programmed Cell Death 1 Receptor
1
2017
38
0.150
 Why?
Mice
8
2023
5720
0.150
 Why?
HLA Antigens
4
2006
51
0.150
 Why?
Receptors, Notch
1
2017
27
0.150
 Why?
Human Umbilical Vein Endothelial Cells
2
2014
90
0.140
 Why?
Neoplastic Stem Cells
1
2017
103
0.140
 Why?
Carcinoma, Papillary
3
2005
48
0.140
 Why?
Adult
15
2011
13160
0.130
 Why?
Poliovirus Vaccine, Oral
2
2005
4
0.130
 Why?
Genetic Vectors
3
2011
127
0.130
 Why?
Poliovirus
2
2005
10
0.130
 Why?
Clinical Trials, Phase I as Topic
1
2015
25
0.130
 Why?
Neoplasm Proteins
1
2017
323
0.130
 Why?
Adenocarcinoma
3
2004
401
0.120
 Why?
Antigen Presentation
5
2009
25
0.120
 Why?
Galectin 3
1
2014
14
0.120
 Why?
Kallikreins
2
2005
18
0.120
 Why?
Neoplasm Invasiveness
3
2017
268
0.120
 Why?
Cystadenocarcinoma, Papillary
2
2005
14
0.120
 Why?
Histocompatibility Antigens Class I
2
2005
44
0.120
 Why?
Peptide Fragments
4
2009
216
0.110
 Why?
Endometrial Neoplasms
2
2005
137
0.110
 Why?
Uterine Neoplasms
2
2005
60
0.110
 Why?
Papillomavirus Infections
3
2011
155
0.110
 Why?
Mutation
1
2019
1293
0.110
 Why?
Mice, Inbred C57BL
3
2017
1806
0.110
 Why?
Intracellular Signaling Peptides and Proteins
2
2022
142
0.100
 Why?
Lymphocytes
1
2013
151
0.100
 Why?
Killer Cells, Natural
4
2005
95
0.100
 Why?
Antigens, Viral
3
2007
44
0.100
 Why?
V-Set Domain-Containing T-Cell Activation Inhibitor 1
1
2011
4
0.100
 Why?
rho GTP-Binding Proteins
1
2011
6
0.100
 Why?
Clonal Anergy
1
2011
13
0.100
 Why?
A Kinase Anchor Proteins
1
2011
2
0.100
 Why?
Drug Resistance, Neoplasm
5
2017
308
0.100
 Why?
Calmodulin-Binding Proteins
1
2011
10
0.100
 Why?
Antigen-Presenting Cells
1
2011
26
0.100
 Why?
Antigens, Surface
1
2011
54
0.100
 Why?
Human papillomavirus 16
1
2011
44
0.100
 Why?
Antineoplastic Agents, Alkylating
1
2011
74
0.100
 Why?
Uterine Cervical Dysplasia
1
2011
49
0.100
 Why?
Immunity, Cellular
2
2008
69
0.100
 Why?
Cyclophosphamide
1
2011
165
0.090
 Why?
Prostate
1
2011
117
0.090
 Why?
Diphosphonates
1
2011
90
0.090
 Why?
Imidazoles
1
2011
119
0.090
 Why?
Phenotype
1
2013
727
0.090
 Why?
Gene Expression Regulation, Neoplastic
4
2011
829
0.090
 Why?
Papillomaviridae
3
2005
102
0.090
 Why?
Gene Expression Profiling
2
2005
1031
0.090
 Why?
Neoplasm Staging
3
2007
746
0.090
 Why?
Tumor Microenvironment
2
2023
210
0.080
 Why?
K562 Cells
2
2008
42
0.080
 Why?
Carrier Proteins
1
2011
304
0.080
 Why?
CA-125 Antigen
1
2008
17
0.080
 Why?
Cytomegalovirus
1
2008
26
0.080
 Why?
Immediate-Early Proteins
1
2008
19
0.080
 Why?
Green Fluorescent Proteins
1
2008
90
0.080
 Why?
RNA, Messenger
4
2005
1105
0.080
 Why?
Interleukin-4
2
2005
43
0.080
 Why?
Antibody Formation
1
2007
56
0.080
 Why?
Antibodies, Viral
1
2007
88
0.070
 Why?
Prostatic Neoplasms
1
2011
396
0.070
 Why?
Amino Acid Sequence
2
2005
587
0.070
 Why?
RNA Interference
2
2017
179
0.070
 Why?
Ovary
3
2017
104
0.070
 Why?
Molecular Sequence Data
2
2005
797
0.070
 Why?
Oligonucleotide Array Sequence Analysis
2
2005
412
0.070
 Why?
Recombinant Proteins
1
2007
486
0.070
 Why?
Hypersensitivity, Delayed
1
2005
21
0.070
 Why?
Breast Neoplasms
3
2003
1169
0.070
 Why?
Neoplasms, Squamous Cell
1
2005
7
0.070
 Why?
Monocytes
2
2022
132
0.060
 Why?
Electroporation
1
2005
17
0.060
 Why?
Poliomyelitis
1
2005
5
0.060
 Why?
Enterotoxins
1
2005
12
0.060
 Why?
Cell Line
4
2010
1002
0.060
 Why?
Gene Transfer Techniques
1
2005
37
0.060
 Why?
Genes, erbB-2
1
2005
8
0.060
 Why?
Interleukin-12
1
2005
31
0.060
 Why?
Immunologic Memory
1
2005
30
0.060
 Why?
Antigens, Heterophile
1
2005
1
0.060
 Why?
Plasmodium falciparum
1
2005
14
0.060
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2008
595
0.060
 Why?
Malaria, Falciparum
1
2005
9
0.060
 Why?
Endemic Diseases
1
2005
22
0.060
 Why?
Burkitt Lymphoma
1
2005
28
0.060
 Why?
Epstein-Barr Virus Infections
1
2005
31
0.060
 Why?
Gangliosides
1
2004
5
0.060
 Why?
Ascitic Fluid
1
2004
12
0.060
 Why?
Genetic Therapy
1
2005
114
0.060
 Why?
Proteins
2
2005
341
0.060
 Why?
Vaccines, Subunit
1
2004
15
0.060
 Why?
Ovariectomy
1
2004
119
0.060
 Why?
Hysterectomy
1
2004
88
0.060
 Why?
Immunization, Passive
1
2004
29
0.060
 Why?
Clinical Trials as Topic
2
2007
460
0.060
 Why?
Interleukin-6
1
2005
264
0.060
 Why?
Tumor Necrosis Factor-alpha
2
2019
388
0.060
 Why?
Cell Differentiation
2
2004
653
0.060
 Why?
Protein Binding
1
2005
660
0.060
 Why?
Epithelial Cells
1
2005
209
0.050
 Why?
Virus Latency
1
2003
47
0.050
 Why?
Vaccinia virus
1
2022
6
0.050
 Why?
Cell Adhesion Molecules
1
2003
85
0.050
 Why?
Host Specificity
1
2022
5
0.050
 Why?
Cell Communication
1
2003
69
0.050
 Why?
Nucleotidyltransferases
1
2022
14
0.050
 Why?
Mammals
1
2022
56
0.050
 Why?
Tumor Cells, Cultured
4
2003
465
0.050
 Why?
Xenograft Model Antitumor Assays
2
2017
210
0.050
 Why?
Disease Progression
2
2019
822
0.050
 Why?
Rabbits
1
2022
370
0.050
 Why?
Radiotherapy
1
2002
128
0.050
 Why?
Down-Regulation
1
2003
349
0.050
 Why?
Blood Transfusion
1
2002
121
0.050
 Why?
Viral Proteins
1
2022
155
0.050
 Why?
Immunohistochemistry
4
2005
971
0.050
 Why?
Carcinoma, Squamous Cell
1
2004
319
0.050
 Why?
Transcriptome
1
2022
313
0.040
 Why?
Endothelium
1
2019
39
0.040
 Why?
Intercellular Adhesion Molecule-1
1
2019
63
0.040
 Why?
Gene Expression
3
2008
608
0.040
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2004
987
0.040
 Why?
Injections, Intraperitoneal
2
2010
54
0.040
 Why?
Tissue Banks
1
2017
9
0.040
 Why?
Antibodies, Monoclonal, Humanized
3
2004
222
0.040
 Why?
Mice, Inbred NOD
1
2017
96
0.040
 Why?
STAT3 Transcription Factor
1
2017
81
0.040
 Why?
Glycosylation
1
2017
100
0.040
 Why?
Tumor Burden
1
2017
132
0.040
 Why?
RNA, Small Interfering
1
2017
215
0.040
 Why?
Multiple Myeloma
1
2011
2910
0.030
 Why?
Lung Neoplasms
1
2002
605
0.030
 Why?
Protein Processing, Post-Translational
1
2017
171
0.030
 Why?
Kaplan-Meier Estimate
1
2017
469
0.030
 Why?
Survival Analysis
2
2010
659
0.030
 Why?
Apoptosis
2
2014
1100
0.030
 Why?
Pore Forming Cytotoxic Proteins
2
2005
9
0.030
 Why?
Perforin
2
2005
11
0.030
 Why?
Anti-Bacterial Agents
1
2019
743
0.030
 Why?
Neovascularization, Pathologic
1
2014
161
0.030
 Why?
Interleukin-2
2
2003
72
0.030
 Why?
Membrane Glycoproteins
2
2005
240
0.030
 Why?
Vaginal Smears
1
2011
28
0.020
 Why?
Organ Specificity
1
2011
108
0.020
 Why?
Prostate-Specific Antigen
1
2011
47
0.020
 Why?
DNA, Viral
1
2011
133
0.020
 Why?
Major Histocompatibility Complex
1
2010
11
0.020
 Why?
Time Factors
2
2010
2912
0.020
 Why?
Prognosis
2
2005
1952
0.020
 Why?
Transduction, Genetic
1
2008
45
0.020
 Why?
Fluorescent Antibody Technique
1
2008
108
0.020
 Why?
Leukocytes, Mononuclear
1
2008
116
0.020
 Why?
T-Lymphocyte Subsets
1
2007
38
0.020
 Why?
Alphapapillomavirus
1
2007
13
0.020
 Why?
Models, Immunological
1
2007
8
0.020
 Why?
Aged, 80 and over
2
2005
3125
0.020
 Why?
Immune Tolerance
1
2007
95
0.020
 Why?
Adolescent
2
2011
6340
0.020
 Why?
HLA-B Antigens
1
2006
6
0.020
 Why?
Clone Cells
1
2006
74
0.020
 Why?
Immunity, Innate
1
2007
104
0.020
 Why?
Male
3
2011
25093
0.020
 Why?
Claudin-3
1
2005
5
0.020
 Why?
Claudin-4
1
2005
7
0.020
 Why?
Combined Modality Therapy
1
2007
636
0.020
 Why?
Mice, Inbred C3H
1
2005
81
0.020
 Why?
Peptides
1
2006
222
0.020
 Why?
Protein Sorting Signals
1
2005
9
0.020
 Why?
Protein Engineering
1
2005
18
0.020
 Why?
Histocompatibility Antigens Class II
1
2005
37
0.020
 Why?
Plasmids
1
2005
159
0.020
 Why?
Mice, SCID
1
2005
175
0.020
 Why?
Disease Models, Animal
1
2010
1451
0.020
 Why?
Species Specificity
1
2005
193
0.020
 Why?
Protein Folding
1
2005
49
0.020
 Why?
Epithelium
1
2004
65
0.020
 Why?
Endocytosis
1
2005
57
0.020
 Why?
Radiotherapy, Adjuvant
1
2004
57
0.020
 Why?
Carboplatin
1
2004
53
0.020
 Why?
Receptors, Cell Surface
1
2005
121
0.020
 Why?
Paclitaxel
1
2004
84
0.010
 Why?
Antineoplastic Agents, Hormonal
1
2004
47
0.010
 Why?
Transfection
1
2005
357
0.010
 Why?
Polymerase Chain Reaction
1
2005
455
0.010
 Why?
Antibody-Dependent Cell Cytotoxicity
1
2003
12
0.010
 Why?
Tumor Stem Cell Assay
1
2003
17
0.010
 Why?
Proportional Hazards Models
1
2005
406
0.010
 Why?
Cervix Uteri
1
2004
49
0.010
 Why?
Swine
1
2005
391
0.010
 Why?
Up-Regulation
1
2005
450
0.010
 Why?
Keratinocytes
1
2004
89
0.010
 Why?
Kinetics
1
2005
626
0.010
 Why?
Receptors, Interleukin-2
1
2002
7
0.010
 Why?
Lymphocyte Subsets
1
2002
13
0.010
 Why?
Leukocytes
1
2003
66
0.010
 Why?
Receptors, Antigen, T-Cell
1
2003
50
0.010
 Why?
Antigens, CD19
1
2002
24
0.010
 Why?
Cell Culture Techniques
1
2003
99
0.010
 Why?
Receptors, IgG
1
2002
22
0.010
 Why?
Doxorubicin
1
2004
230
0.010
 Why?
Cell Death
1
2003
181
0.010
 Why?
Immunophenotyping
1
2002
109
0.010
 Why?
Cisplatin
1
2004
278
0.010
 Why?
Survival Rate
1
2005
905
0.010
 Why?
Tumor Virus Infections
1
2002
43
0.010
 Why?
Antibodies, Monoclonal, Murine-Derived
1
2002
47
0.010
 Why?
Young Adult
1
2011
3936
0.010
 Why?
Fatal Outcome
1
2002
195
0.010
 Why?
Cell Division
1
2002
292
0.010
 Why?
Case-Control Studies
1
2004
1128
0.010
 Why?
Prospective Studies
1
2004
2344
0.010
 Why?
Risk Factors
1
2004
3619
0.010
 Why?
Antineoplastic Agents
1
2002
1172
0.010
 Why?
Cannon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (295) concept(s)
_
Co-Authors Expand Description
See all (22) people
_
Similar People Expand Description
See all (34) people
_
Same Department Expand Description
Search Department